BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1438406)

  • 21. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Shin HJ; Chung JS; Cho GJ
    Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of etoposide in combination with cyclosporine for purging multidrug resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Prog Clin Biol Res; 1992; 377():25-34. PubMed ID: 1438422
    [No Abstract]   [Full Text] [Related]  

  • 23. [Autologous bone marrow transplantation in acute lymphoblastic leukemia].
    Tura S; Visani G; Gamberi B
    Haematologica; 1991 Jun; 76 Suppl 3():327-36. PubMed ID: 1684347
    [No Abstract]   [Full Text] [Related]  

  • 24. 4-Hydroperoxycyclophosphamide treatment of stored bone marrow grafts.
    Davis JM; Schepers KG; Noga SJ; Jones RJ
    Prog Clin Biol Res; 1994; 389():3-7. PubMed ID: 7700912
    [No Abstract]   [Full Text] [Related]  

  • 25. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
    Houtenbos I; Bracho F; Davenport V; Slack R; van de Ven C; Suen Y; Killen R; Shen V; Cairo MS
    Bone Marrow Transplant; 2001 Jan; 27(2):145-53. PubMed ID: 11281383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
    Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
    Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
    Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
    Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
    [No Abstract]   [Full Text] [Related]  

  • 28. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia.
    Körbling M; Knauf W; Funderud S; Kvalheim G; Hunstein W
    Haematologica; 1991 Mar; 76 Suppl 1():29-36. PubMed ID: 1650742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
    Linker CA; Ries CA; Damon LE; Rugo HS; Wolf JL
    Bone Marrow Transplant; 1998 Nov; 22(9):865-72. PubMed ID: 9827814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous bone marrow transplantation and pharmacological bone marrow purging: in vitro use of maphosphamide and bleomycin.
    Visani G; Rizzoli V; Dinota A; Aglietta M; Bernabei PA; Geraci L; Leoni P; Mangoni L; Meloni G; Motta MR
    Haematologica; 1988; 73(3):179-81. PubMed ID: 2458996
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
    Alonso K; Medenica R; Morehead G
    Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
    Frondoza CG; Sinha S; Trivedi SM; Humphrey RL; Colvin OM
    Exp Hematol; 1987 Jul; 15(6):715-8. PubMed ID: 3297761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
    Passos-Coelho J; Ross AA; Davis JM; Huelskamp AM; Clarke B; Noga SJ; Davidson NE; Kennedy MJ
    Cancer Res; 1994 May; 54(9):2366-71. PubMed ID: 8162582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purging procedures for acute leukaemias in autologous BMT.
    Rizzoli V; Mangoni L; Carella AM; Coleselli P; Angrilli F; Alessandrino EP; Miniero A; Novarino A; Falda M; Mozzana R
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():77-80. PubMed ID: 2697443
    [No Abstract]   [Full Text] [Related]  

  • 37. [Autologous bone marrow transplantation in pediatric cancer].
    Ohira M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
    Lenarsky C; Weinberg K; Petersen J; Nolta J; Brooks J; Annett G; Kohn D; Parkman R
    Bone Marrow Transplant; 1990 Dec; 6(6):425-9. PubMed ID: 2097012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of amifostine in bone marrow purging.
    Cagnoni PJ; Jones RB; Bearman SI; Ross M; Hami L; Franklin WA; Capizzi R; Schein PS; Shpall EJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):44-8. PubMed ID: 8783666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD; Eaves AC; Wolpe S; Eaves CJ
    Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.